Skip to content
Sunday 9 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,901.09
+0.31%
DAX
26,319.45
+0.69%
CAC 40
8,714.93
+0.17%
STOXX 50
6,523.86
+0.33%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Sunday 18 November 2018 6:32 pm  |  Updated:  Monday 03 June 2019 2:28 am

Goldman Sachs offers UK staff gender-reassignment and fertility treatment as it tackles boys’ club image

By: Louis Ashworth

Add as a preferred source on Google

Goldman Sachs is offering its staff in London gender-reassignment surgery and fertility treatment, as it pushes on perks in an attempt to encourage women to work at the firm.

The giant investment bank’s roughly 6,000 UK staff will have access to treatment and consultation for gender dysphoria, and an assisted fertility benefit that will include IVF treatment.

Chief executive Richard Gnodde told London staff about the new perks last week. The UK office’s new position on gender-reassignment surgery bringing it up to speed with Goldman’s US office, which has had the policy since 2008, and in line with Silicon Valley giants such as Netflix, and management consultancy giant Accenture.

Its offer of funded fertility consultations and treatments is part of a drive to fix the firm’s gender imbalance. It has frequently been labelled as an old boys’ club, and has a yawning mean gender pay gap of 72.2 per cent in Europe. The firm has said there is “significant work to do” for it to correct its gender imbalances, which include a hugely male-dominated partner class.

Goldman has announced a target to have half its newly-recruited analysts be women by 2021.

Announcing the fertility treatments, the firm said: “We believe we are the first to introduce a guided pathway to ensure that in addition to providing fertility benefits, we are also partnering with a clinical group to ensure employees and dependants have support through process.”

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money
  • News

Categories

  • Business
  • Personal Development

Related Topics

  • Goldman Sachs

Trending Articles

  • Thames Water faces fresh threat to survival after pensions regulation breach

  • PwC’s Embankment HQ to get major makeover ahead of Canary Wharf move

  • Family feud: London estate agent Winkworth sues chair over plot with wife to oust son from board

  • As it happened: Stocks rise despite new tensions in Strait of Hormuz; Oil price climbs

  • A tribute to wine legend Matthew Jukes by his friend Libby Brodie

More from Morning Wire

  • Britain should look to Japan to manage its ageing population

    Opinion
    Elderly pedestrians crossing a busy street in Tokyo, illustrating Japans ageing population challenge.
  • Goldman Sachs criticises £1.45m paternity payout

    Lawsuit
    Goldman Sach bosses said that US stocks were increasingly less preferable than those in the UK and Europe.
  • UK’s biggest pub firm probed over treatment of tenants

    Hospitality
    Stonegate street scene with historic architecture, bustling crowds, and local shops, capturing vibrant city life ambiance.
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • The Debate: should Andy Burnham have made a woman his Chancellor?

    Opinion
    Rachel Reeves delivering a speech at a press event, wearing a navy blazer and standing in front of a backdrop with logos.
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook